Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer - Concepedia

Concepedia

Publication | Open Access

Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer

DOI Full Paper Access

38

Citations

24

References

2019

Year

Chethan Ramamurthy, Elizabeth A. Handorf, Andres Correa, J. Robert Beck, Daniel M. Geynisman

Urologic Oncology Seminars and Original Investigations

UrologyOncologyCancer ManagementPharmacotherapyCancer TreatmentProstatic DiseaseMedicineAbiraterone Versus Docetaxel

References

	Year	Citations

Page 1